drugset / Trial / NCT01442272

Value Antiproteinuric Effects From Vitamin D Derivatives in Patient With Chronic Kidney Illness and the Lack of Vitamin D

NCT01442272

Phase 4 Unknown 174 enrolled Hospital Universitario de Canarias
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the value the additional antiproteinuric effects of vitamin D derivatives treatment, in patients with Chronic Kidney Illness phase II-IV, with lack of vitamin D and residual proteinuria higher 0,5 grams/day.

Timeline

Start
2012-01
Primary completion
2012-10
Completion
2013-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Calcifediol Unknown 266 ug Oral
Comparator Paricalcitol Other / unclassified 1 ug Oral